SNYR

+ Watchlist + Portfolio

Synergy CHC Corp.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $0.11
52-Week Range: $0.09 – $3.18
Market Cap: —
P/E (TTM): —
EPS (TTM): -1.60
Dividend Yield: —

Advanced Metrics

Price/Book: —
PEG Ratio: —
Return on Equity: —
Return on Assets: -62.02%
Gross Margin: 65.37%
Operating Margin: -10.32%
Profit Margin: -56.98%
Current Ratio: 0.93
Debt/Equity: —
Total Debt: $27.75M
Free Cash Flow: $1.81M
Revenue Growth: -32.80%
Earnings Growth: —
Enterprise Value: $29.05M

SNYR Income statement, annual periods, in USD
USD	FY2023	FY2024	FY2025
Revenue	$42.78M	$34.83M	$30.38M
Cost of Revenue	$10.70M	$11.19M	$10.08M
Gross Profit	$32.08M	$23.64M	$20.30M
Selling, General & Admin	$21.24M	$17.71M	$21.97M
Operating Expenses	$21.27M	$17.84M	$22.10M
Operating Income	$10.81M	$5.80M	-$1.80M
EBITDA	$10.84M	$6.47M	-$6.17M
Pretax Income	$6.57M	$2.23M	-$12.22M
Income Tax	$234.98K	$102.08K	$117.47K
Net Income	$6.34M	$2.12M	-$12.34M
Diluted EPS	0.86	0.28	-1.27
Diluted Shares	7.37M	7.63M	9.72M

SNYR Balance Sheet statement, annual periods, in USD
USD	FY2023	FY2024	FY2025
Cash & Equivalents	$632.53K	$687.92K	$2.62M
Receivables	$6.57M	$11.70M	$3.20M
Inventory	$3.73M	$1.72M	$3.74M
Current Assets	$11.82M	$16.06M	$10.01M
Total Assets	$12.24M	$16.34M	$10.16M
Current Liabilities	$14.02M	$17.18M	$8.24M
Long-Term Debt	$25.52M	$15.79M	$25.06M
Total Debt	$27.62M	$27.52M	$26.81M
Total Liabilities	$39.55M	$32.97M	$33.29M
Retained Earnings	-$46.22M	-$44.10M	-$56.44M
Shareholders' Equity	-$27.31M	-$16.63M	-$23.13M
Working Capital	-$2.20M	-$1.12M	$1.78M
Net Debt	$26.99M	$26.83M	$24.19M

SNYR Cash Flow statement, annual periods, in USD
USD	FY2023	FY2024	FY2025
Operating Cash Flow	$421.73K	-$4.80M	-$2.59M
Free Cash Flow	$421.73K	-$4.80M	-$2.59M
Depreciation & Amortisation	$33.33K	$133.33K	$133.33K
Stock-Based Compensation	—	$0.00	$983.31K
Investing Cash Flow	$0.00	$0.00	$0.00
Financing Cash Flow	-$2.09M	$4.80M	$4.65M
Net Change in Cash	-$1.67M	$696.00	$2.07M

SNYR Income statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Revenue	$8.17M	$8.13M	$8.01M	$6.07M	$5.49M
Cost of Revenue	$2.01M	$1.90M	$2.33M	$3.85M	$1.52M
Gross Profit	$6.16M	$6.24M	$5.68M	$2.22M	$3.97M
Selling, General & Admin	$4.18M	$4.58M	$4.37M	$8.84M	$4.50M
Operating Expenses	$4.22M	$4.61M	$4.40M	$8.87M	$4.54M
Operating Income	$1.95M	$1.62M	$1.28M	-$6.65M	-$567.12K
EBITDA	$1.99M	$3.80M	$1.31M	-$13.27M	-$537.16K
Pretax Income	$864.80K	$1.66M	$114.22K	-$14.87M	-$2.58M
Income Tax	-$11.46K	$190.11K	-$11.11K	-$50.07K	-$13.72K
Net Income	$876.26K	$1.47M	$125.33K	-$14.82M	-$2.57M
Diluted EPS	0.10	0.17	0.01	—	-0.23
Diluted Shares	8.58M	8.93M	10.11M	—	11.30M

SNYR Balance Sheet statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Cash & Equivalents	$177.88K	$1.46M	$1.01M	$2.62M	$292.12K
Receivables	$10.61M	$13.52M	$13.40M	$3.20M	$1.27M
Inventory	$2.35M	$2.36M	$2.15M	$3.74M	$3.38M
Current Assets	$15.41M	$19.51M	$20.51M	$10.01M	$6.34M
Total Assets	$15.66M	$19.73M	$20.69M	$10.16M	$6.46M
Current Liabilities	$8.07M	$7.13M	$3.83M	$8.24M	$6.85M
Long-Term Debt	$23.23M	$24.98M	$25.11M	$25.06M	$25.02M
Total Debt	$28.12M	$26.87M	$25.11M	$26.81M	$27.75M
Total Liabilities	$31.30M	$32.11M	$28.94M	$33.29M	$31.87M
Retained Earnings	-$43.22M	-$41.75M	-$41.62M	-$56.44M	-$59.01M
Shareholders' Equity	-$15.64M	-$12.38M	-$8.25M	-$23.13M	-$25.41M
Working Capital	$7.34M	$12.38M	$16.68M	$1.78M	-$503.86K
Net Debt	$27.94M	$25.42M	$24.11M	$24.19M	$27.46M

SNYR Cash Flow statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Operating Cash Flow	-$822.78K	-$76.95K	-$2.31M	$624.13K	-$2.04M
Free Cash Flow	-$822.78K	-$76.95K	-$2.31M	$624.13K	-$2.04M
Depreciation & Amortisation	$33.33K	$33.33K	$33.33K	$33.33K	$33.33K
Stock-Based Compensation	$0.00	$0.00	$867.00K	$116.31K	$116.31K
Investing Cash Flow	$0.00	—	—	$0.00	$0.00
Financing Cash Flow	$314.68K	$1.32M	$1.88M	$1.14M	-$307.60K
Net Change in Cash	-$508.10K	$1.24M	-$426.00K	$1.76M	-$2.35M

Market Snapshot

About

Synergy CHC Corp. is a consumer healthcare company developing and commercializing over-the-counter products and dietary supplements. The company focuses on innovative formulations for pain management, sleep aids, and wellness products. Synergy markets its products through retail, e-commerce, and healthcare professional channels.